News | January 10, 2023
ProBioGen collaborates with Boehringer Ingelheim on DirectedLuck transposase technology
The new project further expands the partner's long-term collaboration on new technologies for R&D
The new project further expands the partner's long-term collaboration on new technologies for R&D
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
The company is one of the most profitable companies manufacturing speciality chemicals in India
Having a healthy gut is key as it permits the body to build a stronger immune system
All claims against the company in the litigation have now been dismissed.
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
Subscribe To Our Newsletter & Stay Updated
